- Home
- RLGT vs ABEO Comparison
RLGT vs ABEO Comparison
Compare RLGT & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLGT | ABEO |
|---|---|---|
| Founded | 2001 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 291.6M | 281.0M |
| IPO Year | N/A | 1980 |
Fundamental Metrics
Financial Performance| Metric | RLGT | ABEO |
|---|---|---|
| Price | $6.74 | $5.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $8.00 | ★ $18.20 |
| AVG Volume (30 Days) | 154.2K | ★ 1.6M |
| Earning Date | 11-10-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 72.35 | N/A |
| EPS | 0.31 | ★ 1.29 |
| Revenue | ★ $925,786,000.00 | $400,000.00 |
| Revenue This Year | $3.77 | N/A |
| Revenue Next Year | $3.51 | $1,590.36 |
| P/E Ratio | $21.55 | ★ $4.17 |
| Revenue Growth | ★ 16.42 | N/A |
| 52 Week Low | $5.44 | $3.93 |
| 52 Week High | $7.94 | $7.54 |
Technical Indicators
Market Signals| Indicator | RLGT | ABEO |
|---|---|---|
| Relative Strength Index (RSI) | 66.34 | 52.37 |
| Support Level | $6.67 | $4.53 |
| Resistance Level | $6.86 | $5.61 |
| Average True Range (ATR) | 0.16 | 0.27 |
| MACD | 0.05 | 0.08 |
| Stochastic Oscillator | 77.91 | 50.70 |
Price Performance
Historical ComparisonAbout RLGT Radiant Logistics Inc.
Radiant Logistics Inc operates as a third-party logistics company, providing multi-modal transportation and logistics services to customers based in the United States and Canada. The company offers domestic and international air and ocean freight forwarding services and freight brokerage services including truckload services, less-than-truckload (LTL) services, and intermodal services. It has two geographic operating segments: the United States and Canada. Maximum revenue is generated in the United States.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.